Reason for request
Re-assessment of the Actual Benefit and Renewal of inclusion
Clinical Benefit
| Low |
The actual benefit of the proprietary medicinal product NUCTALON is low in the treatment of "severe sleep disorders in the following cases: occasional insomnia, transient insomnia. " |
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
057JnDkLVk9vgFHZ
